Similarweb posts 2025 results and 2026 growth outlook
Similarweb Ltd. reported fourth-quarter and full-year 2025 results, with Q4 revenue rising 11% to $72.8 million and full-year revenue up 13% to $282.6 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Similarweb Ltd. reported fourth-quarter and full-year 2025 results, with Q4 revenue rising 11% to $72.8 million and full-year revenue up 13% to $282.6 million. Non-GAAP operating profit was $3.4 million in Q4 and $9.1 million for the year, while GAAP net loss widened to $32.9 million.
The company highlighted growing traction in AI-related products, with generative AI data and solutions contributing 11% of Q4 revenue and its GenAI intelligence product reaching about $3 million in ARR from roughly 200 customers. Multi-year subscriptions increased to 60% of ARR, remaining performance obligations grew 17% to $288.8 million, and 2025 marked the ninth consecutive quarter of positive free cash flow.
For 2026, Similarweb guides to total revenue of $305.0–$315.0 million, implying around 10% growth at the midpoint, and expects non-GAAP operating profit between $16.0 million and $19.0 million, while continuing to focus on AI-driven offerings and disciplined, profitable growth.
Insights
Moderate revenue growth, rising AI mix, but profitability remains limited.
Similarweb posted 2025 revenue of $282.6 million, up 13% year over year, with Q4 revenue of $72.8 million up 11%. Growth is increasingly supported by AI offerings, as generative AI data and solutions reached 11% of Q4 revenue.
Profitability is still modest. GAAP net loss widened to $32.9 million, and non-GAAP operating profit declined to $9.1 million for 2025, though Q4 non-GAAP margin improved to 5%. Net retention softened, with overall NRR at 98% and 103% for large customers, down from prior-year levels.
On the other hand, cash generation and revenue visibility improved. 2025 free cash flow was $13.0 million, cash stood at $72.4 million with no debt as of December 31 2025, multi-year contracts rose to 60% of ARR, and remaining performance obligations increased 17% to $288.8 million. Guidance for 2026 points to roughly 10% revenue growth and higher non-GAAP operating profit of $16.0–$19.0 million, contingent on execution in AI products and enterprise sales.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How did Similarweb (SMWB) perform financially in Q4 2025?
What were Similarweb’s full-year 2025 results and profitability metrics?
How important are AI-related products to Similarweb’s 2025 results?
What does Similarweb’s 2026 revenue and profit guidance indicate?
How strong is Similarweb’s customer base and retention exiting 2025?
What is Similarweb’s cash and free cash flow position as of year-end 2025?
AI-generated analysis. How Rhea-AI works. Not financial advice.
| Exhibit No. | Description | |||||||
99.1 | Press Release of Similarweb Ltd., dated February 17, 2026 | |||||||
99.2 | Shareholder letter, dated February 17, 2026 | |||||||
| Similarweb Ltd. | ||||||||
Date: February 17, 2026 | By: | /s/ Ran Vered | ||||||
Ran Vered Chief Financial Officer | ||||||||
Consolidated Balance Sheets
U.S. dollars in thousands (except share and per share data)
| December 31, | December 31, | ||||||||||
| 2024 | 2025 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 63,869 | $ | 72,421 | |||||||
| Restricted deposits | 10,572 | 6,360 | |||||||||
| Accounts receivable, net | 50,975 | 54,063 | |||||||||
| Deferred contract costs | 11,373 | 11,551 | |||||||||
| Prepaid expenses and other current assets | 4,567 | 5,949 | |||||||||
| Total current assets | 141,356 | 150,344 | |||||||||
| Property and equipment, net | 25,921 | 22,040 | |||||||||
| Deferred contract costs, non-current | 9,895 | 8,177 | |||||||||
| Operating lease right-of-use assets | 34,393 | 34,417 | |||||||||
| Goodwill and intangible assets, net | 30,846 | 45,581 | |||||||||
| Other non-current assets | 500 | 586 | |||||||||
| Total assets | $ | 242,911 | $ | 261,145 | |||||||
| Liabilities and shareholders' equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | 12,403 | 13,871 | |||||||||
| Payroll and benefit related liabilities | 20,304 | 20,342 | |||||||||
| Deferred revenue | 108,232 | 112,169 | |||||||||
| Other payables and accrued expenses | 29,330 | 41,342 | |||||||||
| Operating lease liabilities | 6,923 | 8,841 | |||||||||
| Total current liabilities | 177,192 | 196,565 | |||||||||
| Deferred revenue, non-current | 1,172 | 1,226 | |||||||||
| Operating lease liabilities, non-current | 32,809 | 34,455 | |||||||||
| Other long-term liabilities | 4,230 | 5,573 | |||||||||
| Total liabilities | 215,403 | 237,819 | |||||||||
| Shareholders' equity | |||||||||||
Ordinary Shares, NIS 0.01 par value 500,000,000 shares authorized as of December 31, 2024 and December 31, 2025, 82,620,679 and 86,964,370 shares issued as of December 31, 2024 and December 31, 2025, 82,618,511 and 86,962,202 outstanding as of December 31, 2024 and December 31, 2025 , respectively; | 227 | 240 | |||||||||
| Additional paid-in capital | 391,449 | 419,578 | |||||||||
| Accumulated other comprehensive income | 388 | 1,000 | |||||||||
| Accumulated deficit | (364,556) | (397,492) | |||||||||
| Total shareholders' equity | 27,508 | 23,326 | |||||||||
| Total liabilities and shareholders' equity | $ | 242,911 | $ | 261,145 | |||||||
Consolidated Statements of Comprehensive Income (Loss)
| Year Ended December 31, | Three Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | ||||||||||||||||||||
| Revenue | $ | 249,913 | $ | 282,600 | $ | 65,587 | $ | 72,758 | |||||||||||||||
| Cost of revenue | 54,814 | 57,802 | 15,331 | 14,967 | |||||||||||||||||||
| Gross profit | 195,099 | 224,798 | 50,256 | 57,791 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 55,596 | 72,602 | 15,358 | 17,815 | |||||||||||||||||||
| Sales and marketing | 105,476 | 123,667 | 27,573 | 30,476 | |||||||||||||||||||
| General and administrative | 43,691 | 52,093 | 10,885 | 14,197 | |||||||||||||||||||
| Total operating expenses | 204,763 | 248,362 | 53,816 | 62,488 | |||||||||||||||||||
| Loss from operations | (9,664) | (23,564) | (3,560) | (4,697) | |||||||||||||||||||
| Finance income (expenses), net | 134 | (5,210) | (1,101) | (1,633) | |||||||||||||||||||
| Loss before income taxes | (9,530) | (28,774) | (4,661) | (6,330) | |||||||||||||||||||
| Provision for income taxes | 1,927 | 4,162 | 759 | 1,167 | |||||||||||||||||||
| Net loss | $ | (11,457) | $ | (32,936) | $ | (5,420) | $ | (7,497) | |||||||||||||||
| Net loss per share attributable to ordinary shareholders, basic and diluted | $ | (0.14) | $ | (0.39) | $ | (0.07) | $ | (0.09) | |||||||||||||||
| Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted | 80,825,695 | 84,817,195 | 82,073,002 | 86,591,824 | |||||||||||||||||||
| Net loss | $ | (11,457) | $ | (32,936) | $ | (5,420) | $ | (7,497) | |||||||||||||||
| Other comprehensive (loss) income, net of tax | |||||||||||||||||||||||
| Change in unrealized (loss) gain on cashflow hedges | (484) | 612 | 273 | (666) | |||||||||||||||||||
| Total other comprehensive (loss) income, net of tax | (484) | 612 | 273 | (666) | |||||||||||||||||||
| Total comprehensive loss | $ | (11,941) | $ | (32,324) | $ | (5,147) | $ | (8,163) | |||||||||||||||
| Year Ended December 31, | Three Months Ended December 31, | ||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | ||||||||||||||||||||
| Cost of revenue | $ | 812 | $ | 1,024 | $ | 234 | $ | 258 | |||||||||||||||
| Research and development | 5,511 | 6,805 | 1,330 | 1,622 | |||||||||||||||||||
| Sales and marketing | 4,273 | 5,031 | 1,172 | 1,207 | |||||||||||||||||||
| General and administrative | 7,019 | 8,382 | 1,787 | 1,946 | |||||||||||||||||||
| Total | $ | 17,615 | $ | 21,242 | $ | 4,523 | $ | 5,033 | |||||||||||||||
Consolidated Statements of Cash Flows
| Year Ended December 31, | Three Months Ended December 31, | |||||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | |||||||||||||||||||||||
| Cash flows from operating activities: | ||||||||||||||||||||||||||
| Net loss | $ | (11,457) | $ | (32,936) | $ | (5,420) | $ | (7,497) | ||||||||||||||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||||||||||||||||||||
| Depreciation and amortization | 10,528 | 8,989 | 2,516 | 2,319 | ||||||||||||||||||||||
| Finance loss (income) | 500 | (225) | 711 | 128 | ||||||||||||||||||||||
| Unrealized loss (gain) from hedging future transactions | 103 | (32) | 62 | (1) | ||||||||||||||||||||||
| Share-based compensation | 17,615 | 21,242 | 4,523 | 5,033 | ||||||||||||||||||||||
| Gain from sale of equipment | (12) | (31) | (2) | (11) | ||||||||||||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||||||||||||||
| Change in operating lease right-of-use assets and liabilities, net | (1,078) | 3,540 | 226 | 1,285 | ||||||||||||||||||||||
| Increase in accounts receivable, net | (2,127) | (2,291) | (15,488) | (12,225) | ||||||||||||||||||||||
| (Increase) decrease in deferred contract costs | (258) | 1,540 | (1,846) | (1,086) | ||||||||||||||||||||||
| Decrease (increase) in other current assets | 612 | (716) | 1,366 | 181 | ||||||||||||||||||||||
| (Increase) decrease in other non-current assets | (6) | (86) | (89) | 81 | ||||||||||||||||||||||
| Increase (decrease) in accounts payable | 3,597 | 1,451 | 1,313 | (799) | ||||||||||||||||||||||
| Increase in deferred revenue | 6,432 | 2,727 | 10,224 | 7,925 | ||||||||||||||||||||||
| Increase (decrease) in other non-current liabilities | 528 | 156 | 173 | (59) | ||||||||||||||||||||||
| Increase in other liabilities and accrued expenses | 5,197 | 11,316 | 5,149 | 6,208 | ||||||||||||||||||||||
| Net cash provided by operating activities | 30,174 | 14,644 | 3,418 | 1,482 | ||||||||||||||||||||||
| Cash flows from investing activities: | ||||||||||||||||||||||||||
| Purchase of property and equipment, net | (1,430) | (1,490) | (232) | (281) | ||||||||||||||||||||||
| Capitalized internal-use software costs | (1,304) | (163) | (511) | (163) | ||||||||||||||||||||||
| (Increase) decrease in restricted deposits | (552) | 4,212 | (138) | 4,623 | ||||||||||||||||||||||
| Payment for business combinations, net of cash acquired | (15,414) | (15,787) | 28 | — | ||||||||||||||||||||||
| Net cash (used in) provided by investing activities | (18,700) | (13,228) | (853) | 4,179 | ||||||||||||||||||||||
| Cash flows from financing activities: | ||||||||||||||||||||||||||
| Proceeds from exercise of stock options | 4,677 | 4,587 | 953 | 255 | ||||||||||||||||||||||
| Proceeds from employee share purchase plan | 1,486 | 2,324 | 931 | 1,169 | ||||||||||||||||||||||
| Repayment of Credit Facility | (25,000) | — | — | — | ||||||||||||||||||||||
| Net cash (used in) provided by financing activities | (18,837) | 6,911 | 1,884 | 1,424 | ||||||||||||||||||||||
| Effect of exchange rates on cash and cash equivalents | (500) | 225 | (711) | (128) | ||||||||||||||||||||||
| Net (decrease) increase in cash and cash equivalents | (7,863) | 8,552 | 3,738 | 6,957 | ||||||||||||||||||||||
| Cash and cash equivalents, beginning of period | 71,732 | 63,869 | 60,131 | 65,464 | ||||||||||||||||||||||
| Cash and cash equivalents, end of period | $ | 63,869 | $ | 72,421 | $ | 63,869 | $ | 72,421 | ||||||||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||||||||||||||||
| Interest received, net | $ | (1,225) | $ | (1,332) | $ | (291) | $ | (290) | ||||||||||||||||||
| Taxes paid | $ | 1,168 | $ | 1,723 | $ | 303 | $ | 131 | ||||||||||||||||||
| Supplemental disclosure of non-cash financing activities: | ||||||||||||||||||||||||||
| Additions to operating lease right-of-use assets and liabilities | $ | 6,064 | $ | 7,176 | $ | 1,611 | $ | 1,611 | ||||||||||||||||||
| Share-based compensation included in capitalized internal-use software | $ | 104 | $ | 12 | $ | 42 | $ | 12 | ||||||||||||||||||
| Deferred proceeds from exercise of share options included in other current assets | $ | 29 | $ | 6 | $ | 29 | $ | 6 | ||||||||||||||||||
| Deferred costs of property and equipment incurred during the period included in accounts payable | $ | 227 | $ | 137 | $ | 227 | $ | 137 | ||||||||||||||||||
| Year Ended December 31, | Three Months Ended December 31, | |||||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | |||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| GAAP gross profit | $ | 195,099 | $ | 224,798 | $ | 50,256 | $ | 57,791 | ||||||||||||||||||
| Add: | ||||||||||||||||||||||||||
| Share-based compensation expenses | 812 | 1,024 | 234 | 258 | ||||||||||||||||||||||
| Retention payments related to business combinations | 65 | 72 | 21 | 15 | ||||||||||||||||||||||
| Amortization of intangible assets related to business combinations | 4,191 | 1,770 | 815 | 560 | ||||||||||||||||||||||
| Non-GAAP gross profit | $ | 200,167 | $ | 227,664 | $ | 51,326 | $ | 58,624 | ||||||||||||||||||
| Non-GAAP gross margin | 80 | % | 81 | % | 78 | % | 81 | % | ||||||||||||||||||
| Year Ended December 31, | Three Months Ended December 31, | |||||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | |||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| Loss from operations | $ | (9,664) | $ | (23,564) | $ | (3,560) | $ | (4,697) | ||||||||||||||||||
| Add: | ||||||||||||||||||||||||||
| Share-based compensation expenses | 17,615 | 21,242 | 4,523 | 5,033 | ||||||||||||||||||||||
| Retention payments related to business combinations | 1,886 | 7,943 | 539 | 2,076 | ||||||||||||||||||||||
| Amortization of intangible assets related to business combinations | 4,862 | 3,497 | 1,067 | 1,018 | ||||||||||||||||||||||
| Secondary offering costs | 350 | — | — | — | ||||||||||||||||||||||
| Non-GAAP operating profit | $ | 15,049 | $ | 9,118 | $ | 2,569 | $ | 3,430 | ||||||||||||||||||
| Non-GAAP operating margin | 6 | % | 3 | % | 4 | % | 5 | % | ||||||||||||||||||
| Year Ended December 31, | Three Months Ended December 31, | |||||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | |||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| GAAP research and development | $ | 55,596 | $ | 72,602 | $ | 15,358 | $ | 17,815 | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
| Share-based compensation expenses | 5,511 | 6,805 | 1,330 | 1,622 | ||||||||||||||||||||||
| Retention payments related to business combinations | 38 | 2,387 | 11 | 702 | ||||||||||||||||||||||
| Non-GAAP research and development | $ | 50,047 | $ | 63,410 | $ | 14,017 | $ | 15,491 | ||||||||||||||||||
| Non-GAAP research and development margin | 20 | % | 22 | % | 21 | % | 21 | % | ||||||||||||||||||
| GAAP sales and marketing | $ | 105,476 | $ | 123,667 | $ | 27,573 | $ | 30,476 | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
| Share-based compensation expenses | 4,273 | 5,031 | 1,172 | 1,207 | ||||||||||||||||||||||
| Retention payments related to business combinations | 1,783 | 2,888 | 507 | 651 | ||||||||||||||||||||||
| Amortization of intangible assets related to business combinations | 671 | 1,727 | 252 | 458 | ||||||||||||||||||||||
| Non-GAAP sales and marketing | $ | 98,749 | $ | 114,021 | $ | 25,642 | $ | 28,160 | ||||||||||||||||||
| Non-GAAP sales and marketing margin | 40 | % | 40 | % | 39 | % | 39 | % | ||||||||||||||||||
| GAAP general and administrative | $ | 43,691 | $ | 52,093 | $ | 10,885 | $ | 14,197 | ||||||||||||||||||
| Less: | ||||||||||||||||||||||||||
| Share-based compensation expenses | 7,019 | 8,382 | 1,787 | 1,946 | ||||||||||||||||||||||
| Retention payments related to business combinations | — | 2,596 | — | 708 | ||||||||||||||||||||||
| Secondary offering costs | 350 | — | — | — | ||||||||||||||||||||||
| Non-GAAP general and administrative | $ | 36,322 | $ | 41,115 | $ | 9,098 | $ | 11,543 | ||||||||||||||||||
| Non-GAAP general and administrative margin | 15 | % | 15 | % | 14 | % | 16 | % | ||||||||||||||||||
| Year Ended December 31, | Three Months Ended December 31, | |||||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | |||||||||||||||||||||||
| (In thousands, except for share and per share amounts) | (In thousands, except for share and per share amounts) | |||||||||||||||||||||||||
| GAAP Net loss | $ | (11,457) | $ | (32,936) | $ | (5,420) | $ | (7,497) | ||||||||||||||||||
| Add: | ||||||||||||||||||||||||||
| Share-based compensation expenses | 17,615 | 21,242 | 4,523 | 5,033 | ||||||||||||||||||||||
| Retention payments related to business combinations | 1,886 | 7,943 | 539 | 2,076 | ||||||||||||||||||||||
| Amortization of intangible assets related to business combinations | 4,862 | 3,497 | 1,067 | 1,018 | ||||||||||||||||||||||
| Secondary offering costs | 350 | — | — | — | ||||||||||||||||||||||
| Non-operating foreign exchange losses | 224 | 5,718 | 1,196 | 1,729 | ||||||||||||||||||||||
| Tax effect of adjustments, net | (1,850) | (334) | (323) | (86) | ||||||||||||||||||||||
| Non-GAAP net income | $ | 11,630 | $ | 5,130 | $ | 1,582 | $ | 2,273 | ||||||||||||||||||
| Non-GAAP net income margin | 5 | % | 2 | % | 2 | % | 3 | % | ||||||||||||||||||
| Weighted average number of ordinary shares - basic | 80,825,695 | 84,817,195 | 82,073,002 | 86,591,824 | ||||||||||||||||||||||
| Non-GAAP basic net income per share attributable to ordinary shareholders | $ | 0.14 | $ | 0.06 | $ | 0.02 | $ | 0.03 | ||||||||||||||||||
| Weighted average number of ordinary shares - diluted | 86,428,066 | 89,271,537 | 88,666,263 | 89,907,570 | ||||||||||||||||||||||
| Non-GAAP diluted net income per share attributable to ordinary shareholders | $ | 0.13 | $ | 0.06 | $ | 0.02 | $ | 0.03 | ||||||||||||||||||
| Year Ended December 31, | Three Months Ended December 31, | |||||||||||||||||||||||||
| 2024 | 2025 | 2024 | 2025 | |||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| Net cash provided by operating activities | $ | 30,174 | $ | 14,644 | $ | 3,418 | $ | 1,482 | ||||||||||||||||||
| Purchases of property and equipment, net | (1,430) | (1,490) | (232) | (281) | ||||||||||||||||||||||
| Capitalized internal use software costs | (1,304) | (163) | (511) | (163) | ||||||||||||||||||||||
| Free cash flow | $ | 27,440 | $ | 12,991 | $ | 2,675 | $ | 1,038 | ||||||||||||||||||
| Deferred payments related to business combinations | 265 | 1,660 | — | — | ||||||||||||||||||||||
| Normalized free cash flow | $ | 27,705 | $ | 14,651 | $ | 2,675 | $ | 1,038 | ||||||||||||||||||